Protekt Therapeutics
Ness Ziona
About Protekt Therapeutics
ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.1M
- Last round: Series Unknown (Nov 2019)
- Website: protektx.com
- Phone: +972-54-6491370
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/protekt-therapeutics-168001 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.